3,4-O-Isopropylidene ClindaMycin 2-[Bis(2,2,2-trichloroethyl)phosphate]
![3,4-O-Isopropylidene ClindaMycin 2-[Bis(2,2,2-trichloroethyl)phosphate] price.](/CAS/GIF/147621-30-5.gif)
|
- $900 - $3960
- Product name: 3,4-O-Isopropylidene ClindaMycin 2-[Bis(2,2,2-trichloroethyl)phosphate]
- CAS: 147621-30-5
- MF: C25H40Cl7N2O8PS
- MW: 807.8
- EINECS:
- MDL Number:
- Synonyms:3,4-O-Isopropylidene ClindaMycin 2-[Bis(2,2,2-trichloroethyl)phosphate];L-threo-α-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-3,4-O-(1-methylethylidene)-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-, 2-[bis(2,2,2-trichloroethyl) phosphate], (2S-trans)- (9CI)
2 prices
Selected condition：
Brand
- Medical Isotopes, Inc.
- TRC
Package
- 1mg
- 10mg
- ManufacturerMedical Isotopes, Inc.
- Product number59287
- Product description3,4-O-IsopropylideneClindamycin2-[Bis(2,2,2-trichloroethyl)phosphate]
- Packaging1mg
- Price$900
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberI824870
- Product description3,4-O-IsopropylideneClindamycin2-[Bis(2,2,2-trichloroethyl)phosphate]
- Packaging10mg
- Price$3960
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Medical Isotopes, Inc. | 59287 | 3,4-O-IsopropylideneClindamycin2-[Bis(2,2,2-trichloroethyl)phosphate] | 1mg | $900 | 2021-12-16 | Buy |
| TRC | I824870 | 3,4-O-IsopropylideneClindamycin2-[Bis(2,2,2-trichloroethyl)phosphate] | 10mg | $3960 | 2021-12-16 | Buy |
Properties
Boiling point :752.9±60.0 °C(Predicted)
Density :1.46±0.1 g/cm3(Predicted)
storage temp. :-20°C Freezer
solubility :Chloroform, Dichloromethane, Dimethyl Sulfoxide
form :Solid
pka :13.54±0.40(Predicted)
color :Off-white
Density :1.46±0.1 g/cm3(Predicted)
storage temp. :-20°C Freezer
solubility :Chloroform, Dichloromethane, Dimethyl Sulfoxide
form :Solid
pka :13.54±0.40(Predicted)
color :Off-white
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|